Works by Cock I. E.
1
- Pharmacognosy Journal, 2021, v. 13, n. 3, p. 798, doi. 10.5530/pj.2021.13.102
- Tiwana, Gagan;
- Fua, Jiahe;
- Lu, Lanping;
- Cheesman, Matthew J.;
- Cock, I. E.
- Article
2
- Pharmacognosy Journal, 2017, v. 9, n. 4, p. 441, doi. 10.5530/pj.2017.4.74
- Courtney, Reece;
- Sirdaarta, J.;
- White, A.;
- Cock, I. E.
- Article
3
- Pharmacognosy Journal, 2015, v. 7, n. 1, p. 18, doi. 10.5530/pj.2015.7.2
- Courtney, R.;
- Sirdaarta, J.;
- Matthews, B.;
- Cock, I. E.
- Article
4
- Pharmacognosy Journal, 2011, v. 3, n. 20, p. 72, doi. 10.5530/pj.2011.20.14
- Article
5
- Parasitology Research, 2020, v. 119, n. 3, p. 1125, doi. 10.1007/s00436-019-06579-1
- Article
6
- International Journal of Cosmetic Science, 2017, v. 39, n. 5, p. 500, doi. 10.1111/ics.12403
- McManus, K.;
- Wood, A.;
- Wright, M. H.;
- Matthews, B.;
- Greene, A. C.;
- Cock, I. E.
- Article
7
- Pharmacognosy Communications, 2022, v. 12, n. 4, p. 155, doi. 10.5530/pc.2022.4.31
- Article
8
- Pharmacognosy Communications, 2022, v. 12, n. 4, p. 154, doi. 10.5530/pc.2022.4.30
- Article
9
- Pharmacognosy Communications, 2022, v. 12, n. 4, p. 142, doi. 10.5530/pc.2022.4.28
- Batten, Jason;
- Cock, I. E.
- Article
10
- Pharmacognosy Communications, 2022, v. 12, n. 4, p. 125, doi. 10.5530/pc.2022.4.25
- Article
11
- Pharmacognosy Communications, 2022, v. 12, n. 3, p. 122, doi. 10.5530/pc.2022.3.24
- Article
12
- Pharmacognosy Communications, 2022, v. 12, n. 3, p. 121
- Article
13
- Pharmacognosy Communications, 2022, v. 12, n. 3, p. 120, doi. 10.5530/pc.2022.3.23
- Article
14
- Pharmacognosy Communications, 2022, v. 12, n. 3, p. 89, doi. 10.5530/pc.2022.3.18
- Article
15
- Pharmacognosy Communications, 2022, v. 12, n. 2, p. 86, doi. 10.5530/pc.2022.2.17
- Article
16
- Pharmacognosy Communications, 2022, v. 12, n. 2, p. 85
- Article
17
- Pharmacognosy Communications, 2022, v. 12, n. 2, p. 84, doi. 10.5530/pc.2022.2.16
- Article
18
- Pharmacognosy Communications, 2022, v. 12, n. 2, p. 39, doi. 10.5530/pc.2022.2.9
- Article
19
- Pharmacognosy Communications, 2022, v. 12, n. 1, p. 37, doi. 10.5530/pc.2022.1.8
- Article
20
- Pharmacognosy Communications, 2022, v. 12, n. 1, p. 23, doi. 10.5530/pc.2022.1.5
- Chikowe, Getmore Rumbudzai;
- Mpala, Lindiwe Nomathemba;
- Cock, I. E.
- Article
21
- Pharmacognosy Communications, 2022, v. 12, n. 1, p. 1, doi. 10.5530/pc.2022.1.1
- Article
22
- Pharmacognosy Communications, 2021, v. 11, n. 4, p. 215, doi. 10.5530/pc.2021.4.43
- Article
23
- Pharmacognosy Communications, 2021, v. 11, n. 4, p. 214, doi. 10.5530/pc.2021.4.42
- Article
24
- Pharmacognosy Communications, 2021, v. 11, n. 3, p. 174, doi. 10.5530/pc.2021.3.34
- Article
25
- Pharmacognosy Communications, 2021, v. 11, n. 4, p. 176, doi. 10.5530/pc.2021.4.35
- Article
26
- Pharmacognosy Communications, 2021, v. 11, n. 3, p. 173
- Article
27
- Pharmacognosy Communications, 2021, v. 11, n. 3, p. 172, doi. 10.5530/pc.2021.3.33
- Article
28
- Pharmacognosy Communications, 2019, v. 9, n. 1, p. 36, doi. 10.5530/pc.2019.1.8
- Article
29
- Pharmacognosy Communications, 2019, v. 9, n. 1, p. 35, doi. 10.5530/pc.2019.1.x
- Article
30
- Pharmacognosy Communications, 2019, v. 9, n. 1, p. 34, doi. 10.5530/pc.2019.1.7
- Article
31
- Pharmacognosy Communications, 2019, v. 9, n. 1, p. 1, doi. 10.5530/pc.2019.1.1
- Article
32
- Pharmacognosy Communications, 2018, v. 8, n. 4, p. 137, doi. 10.5530/pc.2018.4.29
- Article
33
- Pharmacognosy Communications, 2018, v. 8, n. 4, p. 169
- Article
34
- Pharmacognosy Communications, 2018, v. 8, n. 4, p. 168
- Article
35
- Pharmacognosy Communications, 2018, v. 8, n. 4, p. 170, doi. 10.5530/pc.2018.4.35
- Article
36
- Pharmacognosy Communications, 2018, v. 8, n. 3, p. 135, doi. 10.5530/pc.2018.3.28
- Article
40
- Pharmacognosy Communications, 2017, v. 7, n. 4, p. 172
- Article
42
- Pharmacognosy Communications, 2017, v. 7, n. 3, p. 107, doi. 10.5530/pc.2017.3.15
- Article
43
- Pharmacognosy Communications, 2017, v. 7, n. 2, p. 104
- Article
44
- Pharmacognosy Communications, 2017, v. 7, n. 2, p. 104
- Article
45
- Pharmacognosy Communications, 2017, v. 7, n. 2, p. 102
- Article
46
- Pharmacognosy Communications, 2017, v. 7, n. 2, p. 65, doi. 10.5530/pc.2017.2.9
- Article
47
- Pharmacognosy Communications, 2017, v. 7, n. 1, p. 61
- Article
48
- Pharmacognosy Communications, 2017, v. 7, n. 1, p. 61
- Article
49
- Pharmacognosy Communications, 2016, v. 6, n. 3, p. 187
- Article
50
- Pharmacognosy Communications, 2016, v. 6, n. 3, p. 187
- Article